Trials / Completed
CompletedNCT01206374
Questionnaire and Laboratory Data on Vitiligo Vulgaris
Demographic and Laboratory Data Collection for Patients With Vitiligo Vulgaris
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 57 (actual)
- Sponsor
- St. Luke's-Roosevelt Hospital Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
Detailed description
Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2010-10-01
- Completion
- 2014-09-01
- First posted
- 2010-09-21
- Last updated
- 2015-05-25
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01206374. Inclusion in this directory is not an endorsement.